Procurement Summary
Country: Ukraine
Summary: Lorazepam: Classification According to Inn: Lorazepam, Classification According to Atc: N05Ba06, Release Form: Tablets, Dose of Active Substance: 1 Mg, Packaging Type: Blister; Lorazepam: Classification According to Inn: Loraze...
Deadline: 14 Jan 2026
Posting Date: 11 Jan 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 133498533
Document Ref. No.: UA-2026-01-09-003460-a
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 405140.4
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Lorazepam pharmaceutical products: Classification according to INN: Lorazepam, Classification according to ATX: N05BA06, Release form: Tablets, Dose of active substance: 1 mg, Type of packaging: Blister; Lorazepam: Classification according to INN: Lorazepam, Classification according to ATC: N05BA06, Release form: Solution for injections, Dose of active substance: 2 mg/ml, Type of packaging: Ampoule, Volume: 1 milliliter Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Lorazepam pharmaceutical products: Classification according to INN: Lorazepam, Classification according to ATX: N05BA06, Release form: Tablets, Dose of active substance: 1 mg, Packaging type: Blister; Lorazepam: Classification according to the INN: Lorazepam, Classification according to the ATC: N05BA06, Release form: Solution for injections, Dose of the active substance: 2 mg/ml, Type of packaging: Ampoule, Volume: 1 milliliter Name Classifier and its corresponding code Quantity/Units Place of delivery Delivery date Name Lorazepam: Classification according to the INN: Lorazepam, Classification according to the ATC: N05BA06, Release form: Tablets, Dose of the active substance: 1 mg, Packaging type: Blister, Lorazepam: Classification according to the INN: Lorazepam, Classification according to the ATC: N05BA06, Release form: Solution for injections, Dose of the active ingredient: 2 mg/ml, Packaging type: Ampoule, Volume: 1 milliliter
Documents
Tender Notice